Evening versus morning dosing regimen drug therapy for hypertension
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Evening Versus Morning Dosing Regimen Drug Therapy for Hypertension." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/438549/all/Terlipressin_versus_other_vasoactive_drugs_for_hepatorenal_syndrome:_Cochrane_systematic_review. Accessed 29 March 2024.
Evening versus morning dosing regimen drug therapy for hypertension. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/438549/all/Terlipressin_versus_other_vasoactive_drugs_for_hepatorenal_syndrome:_Cochrane_systematic_review. Accessed March 29, 2024.
Evening versus morning dosing regimen drug therapy for hypertension. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/438549/all/Terlipressin_versus_other_vasoactive_drugs_for_hepatorenal_syndrome:_Cochrane_systematic_review
Evening Versus Morning Dosing Regimen Drug Therapy for Hypertension [Internet]. In: Cochrane Abstracts. [cited 2024 March 29]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/438549/all/Terlipressin_versus_other_vasoactive_drugs_for_hepatorenal_syndrome:_Cochrane_systematic_review.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Evening versus morning dosing regimen drug therapy for hypertension
ID - 438549
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/438549/all/Terlipressin_versus_other_vasoactive_drugs_for_hepatorenal_syndrome:_Cochrane_systematic_review
DB - Evidence Central
DP - Unbound Medicine
ER -